sulfinpyrazone has been researched along with indomethacin in 81 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 65 (80.25) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (11.11) | 29.6817 |
2010's | 6 (7.41) | 24.3611 |
2020's | 1 (1.23) | 2.80 |
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
Topliss, JG; Yoshida, F | 1 |
Beijnen, J; Borst, P; de Haas, M; Evers, R; Lankelma, J; Sparidans, R; Wielinga, PR | 1 |
Beijnen, JH; Borst, P; Reid, G; Saeki, T; Zelcer, N | 1 |
Doman, TN; McGovern, SL; Seidler, J; Shoichet, BK | 1 |
Chang, TK; Ensom, MH; Kiang, TK | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Buttar, D; Colclough, N; Gerhardt, S; MacFaul, PA; Maskos, K; Phillips, SD; Plowright, A; Steinbacher, S; Steuber, H; Tam, K; Whittamore, P | 1 |
Jobin, F | 2 |
Ferber, RH; Parrish, SL; Vigdahl, RL | 1 |
Cameron, JS; Clark, WF; George, CR | 1 |
Emmerson, BT | 1 |
Novo, S; Strano, A | 1 |
Simkin, PA | 1 |
Ciammaichella, A | 1 |
McCarty, DJ | 2 |
Ali, M; Cerskus, AL; McDonald, JW; Zamecnik, J | 1 |
Kelley, WN | 1 |
Thiele, KG | 1 |
Burghardt, B; Cardell, M; Janero, DR; Lopez, R | 1 |
Northover, BJ | 2 |
Lijnen, P | 1 |
Schlapbach, P | 1 |
Toivanen, J; Viinikka, L; Ylikorkala, O | 1 |
Cerletti, C | 1 |
Lo, B | 1 |
Zöllner, N | 1 |
Sans Solá, L | 1 |
Brodie, BB; Maickel, RP; Miller, FP | 1 |
Ciosek, CP; Newcombe, DS; Thanassi, NM | 1 |
Graeme, ML; Sigg, EB; Simke, J | 1 |
Andersen, LA; Gormsen, J | 1 |
Yü, T; Yu, TF | 1 |
Kersley, GD | 2 |
Bluestone, R; Campion, D; Klinenberg, JR; Whitehouse, M | 1 |
Goldfinger, SE | 1 |
Klotz, H; Prohaska, E; Salmhofer, H; Schmid, L | 1 |
Bluestone, R; Kippen, I; Klinenberg, JR | 1 |
Motawakel, AG | 1 |
Bluestone, R; Kippen, I; Klinenberg, JR; Whitehouse, M | 1 |
Peterson, J; Zucker, MB | 1 |
Bluestone, R; Kippen, I; Klinenberg, JR; Whitehouse, MW | 1 |
Riccitelli, ML | 1 |
Graeme, ML; John, M; Sigg, EB | 1 |
English, DK; Gay, JC; Lukens, JN | 1 |
Agostoni, A | 1 |
Jamieson, JC; Kaplan, HA; Kutryk, M; Woloski, BM | 1 |
Birgens, HS; Hansen, MS | 1 |
Mustard, JF; Packham, MA | 1 |
Dahl, ML; Uotila, P | 1 |
O'Flaherty, JT; Stimler, NP | 1 |
Rodnan, GP | 1 |
Innis, JD; Wenzel, DG | 1 |
Matsubara, I | 1 |
Feilhauer, GD; Kühn, P; Mayrhofer, EF; Pilecky, I; Vockner, H | 1 |
Amery, A; Boelaert, J; Daneels, R; Lijnen, P; Schurgers, M | 1 |
Clark, WF; Moriarity, TA; Reid, BD; Tevaarwerk, GJ | 1 |
Koltai, M; Leprán, I; Szekeres, L | 1 |
Obel, AO | 1 |
Butler, KD; Smith, JR | 1 |
Ihnatowycz, IO; Moore, S; Winocour, PD | 1 |
Huijgens, PC; Imandt, LM; Langenhuijsen, MM; van den Berg, CA | 1 |
Rainwater, J; Steele, P | 1 |
Ali, M; Cooper, JD; Klement, P; Masterson, J; McDonald, JW; Menkes, E | 1 |
Dahinden, C; Fehr, J | 1 |
MONTGOMERY, DB; OGRYZLO, MA | 1 |
REAH, TG | 1 |
Anzai, N; Endou, H; Enomoto, A; Fujimura, M; Miyazaki, H; Shin, HJ; Takeda, M | 1 |
Abo Elmaaty, A; Al-Karmalawy, AA; B Elkaeed, E; Hamed, MIA; Ismail, MI; Khattab, M; S Abulkhair, H | 1 |
12 review(s) available for sulfinpyrazone and indomethacin
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
[Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Analgesics; Anti-Inflammatory Agents; Arteriosclerosis; Aspirin; Blood Coagulation; Blood Platelets; Cardiovascular Diseases; Dipyridamole; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; In Vitro Techniques; Indomethacin; Oxyphenbutazone; Phenylbutazone; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Time Factors | 1976 |
The role of platelets in glomerulonephritis.
Topics: Adenosine; Antidepressive Agents; Aspirin; Blood Platelets; Complement System Proteins; Endothelium; Glomerulonephritis; Hemostasis; Heparin; Histamine H1 Antagonists; Humans; Immunity; Immunoglobulins; Indomethacin; Kidney Diseases; Meclofenamic Acid; Mopidamol; Phagocytosis; Phenylbutazone; Platelet Aggregation; Prostaglandins; Pyrimidines; Sulfinpyrazone; Tranquilizing Agents; Warfarin | 1975 |
Drug control of gout and hyperuricaemia.
Topics: Allopurinol; Arthritis; Chronic Disease; Colchicine; Gout; Humans; Indomethacin; Naproxen; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1978 |
[Prospects of antiaggregant therapy in prevention of atherosclerosis].
Topics: Animals; Anti-Inflammatory Agents; Anticoagulants; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Dipyridamole; Epoprostenol; Humans; Hyperlipidemias; Indomethacin; Papaverine; Platelet Aggregation; Prostaglandins; Prostaglandins, Synthetic; Sulfinpyrazone; Xanthines | 1979 |
[Gout: diagnosis and therapy].
Topics: Allopurinol; Colchicine; Gout; Gout Suppressants; Humans; Indomethacin; Probenecid; Sulfinpyrazone | 1985 |
Crystal deposition joint disease.
Topics: Aged; Arthritis, Rheumatoid; Chondrocalcinosis; Colchicine; Crystallization; Diphosphates; Female; Gout; Humans; Indomethacin; Joint Diseases; Male; Phenylbutazone; Probenecid; Sulfinpyrazone; Synovial Fluid; Uric Acid; X-Ray Diffraction | 1974 |
Milestones in the treatment of gout.
Topics: Allopurinol; Colchicine; Gout; Humans; Indomethacin; Kidney Calculi; Probenecid; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1974 |
Treatment of gout.
Topics: Adrenal Cortex Hormones; Allopurinol; Colchicine; Gout; Humans; Indomethacin; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid; Uricosuric Agents; Xanthine Oxidase; Xanthines | 1971 |
Pharmacology of platelet-affecting drugs.
Topics: Animals; Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Platelets; Cyclic AMP; Dose-Response Relationship, Drug; Female; Heparin; Humans; Indomethacin; Male; Papio; Phospholipases; Platelet Adhesiveness; Platelet Function Tests; Rabbits; Sulfinpyrazone; Thrombin; Thromboembolism; Thrombosis; Thromboxane-A Synthase; Vasoconstriction; Ventricular Fibrillation | 1980 |
Treatment of the gout and other forms of crystal-induced arthritis.
Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Benzbromarone; Colchicine; Gout; Gout Suppressants; Humans; Indomethacin; Kidney; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid | 1982 |
1 trial(s) available for sulfinpyrazone and indomethacin
Article | Year |
---|---|
Effect of drugs on urate binding to plasma proteins.
Topics: Adult; Allopurinol; Arthritis; Aspirin; Blood Proteins; Chromatography, DEAE-Cellulose; Colchicine; Female; Gout; Humans; Indomethacin; Male; Phenylbutazone; Probenecid; Protein Binding; Sulfinpyrazone; Uric Acid | 1969 |
68 other study(ies) available for sulfinpyrazone and indomethacin
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export.
Topics: Anion Transport Proteins; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Benzbromarone; Biological Transport, Active; Carrier Proteins; Dose-Response Relationship, Drug; Glutathione; Humans; Indomethacin; Probenecid; Sulfinpyrazone; Tumor Cells, Cultured; Uricosuric Agents; Vinblastine | 2000 |
Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3).
Topics: Animals; Biological Transport; Cell Line; Chromatography, High Pressure Liquid; Cloning, Molecular; DNA, Complementary; Drug Resistance, Multiple; Etoposide; Glutathione; Humans; Mice; Multidrug Resistance-Associated Proteins; Transfection | 2001 |
Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Topics: Antifungal Agents; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry, Physical; Chymotrypsin; Enzyme Inhibitors; Kinetics; Light; Malate Dehydrogenase; Models, Molecular; Molecular Conformation; Scattering, Radiation; Structure-Activity Relationship | 2003 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions.
Topics: Binding Sites; Crystallography, X-Ray; Drug Interactions; Humans; Pharmaceutical Preparations; Protein Binding; Protein Structure, Tertiary; Serum Albumin; Spectrometry, Fluorescence | 2010 |
Evaluation of antiinflammatory and antithrombotic drugs in pulmonary and arterial thrombosis.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Anti-Inflammatory Agents; Arterial Occlusive Diseases; Aspirin; Benzophenones; Carotid Arteries; Cattle; Dipyridamole; Drug Evaluation; Fibrinolytic Agents; Humans; Imidazoles; Indoles; Indomethacin; Lung Diseases, Obstructive; Male; Mice; Platelet Aggregation; Prostaglandins; Pyridines; Quinazolines; Rats; Sulfinpyrazone; Sulfonamides; Suloctidil; Thiophenes | 1979 |
Management of gout.
Topics: Adrenal Cortex Hormones; Allopurinol; Colchicine; Female; Gout; Humans; Indomethacin; Patient Education as Topic; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid | 1979 |
[Current status of vascular diseases and their treatment].
Topics: Arteriosclerosis; Aspirin; Clofibrate; Humans; Indomethacin; Sulfinpyrazone; Vasodilator Agents | 1979 |
The management of gout.
Topics: Allopurinol; Colchicine; Gout; Humans; Indomethacin; Male; Oxyphenbutazone; Phenylbutazone; Probenecid; Sulfinpyrazone | 1979 |
[Platelet-inhibiting drugs].
Topics: Anti-Bacterial Agents; Aspirin; Dextrans; Dipyridamole; Hemorrhage; Humans; Indomethacin; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1978 |
Effects of indomethacin and sulfinpyrazone on in vivo formation of thromboxane B2 and prostaglandin D2 during arachidonate infusion in rabbits.
Topics: Animals; Arachidonic Acids; Blood Platelets; Female; Indomethacin; Infusions, Parenteral; Platelet Aggregation; Prostaglandins; Prostaglandins D; Rabbits; Respiratory Insufficiency; Sulfinpyrazone; Thromboxane B2; Thromboxanes | 1978 |
Drugs for gout.
Topics: Allopurinol; Colchicine; Gout; Humans; Indomethacin; Oxyphenbutazone; Phenylbutazone; Probenecid; Sulfinpyrazone | 1976 |
Current therapy of gout and hyperuricemia.
Topics: Allopurinol; Colchicine; Drug Interactions; Gout; Humans; Indomethacin; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid | 1976 |
[Special pharmacotherapy of primary glomerulonephritis in the adult].
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Anticoagulants; Azathioprine; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Glomerulonephritis; Heparin; Humans; Indomethacin; Nephrotic Syndrome; Prednisone; Sulfinpyrazone | 1975 |
Influence of cardioprotective cyclooxygenase and lipoxygenase inhibitors on peroxidative injury to myocardial-membrane phospholipid.
Topics: Aspirin; Cyclooxygenase Inhibitors; Fatty Acids, Unsaturated; Humans; Indomethacin; Lipid Peroxidation; Lipid Peroxides; Lipoxygenase Inhibitors; Membrane Lipids; Myocardial Reperfusion Injury; Naproxen; Sulfinpyrazone; Superoxides; Time Factors; Xanthine Oxidase | 1989 |
A protective effect of sulphinpyrazone against coronary occlusion-induced shortening of myocardial refractory periods in the rat.
Topics: Action Potentials; Animals; Cardiac Pacing, Artificial; Coronary Disease; Electrocardiography; Heart; Indomethacin; Male; Rats; Rats, Inbred Strains; Sulfinpyrazone | 1986 |
Electrical changes produced by injury to the rat myocardium in vitro and the protective effects of certain antiarrhythmic drugs.
Topics: Animals; Anti-Arrhythmia Agents; Calcium; Coronary Disease; Electric Stimulation; Heart Conduction System; In Vitro Techniques; Indomethacin; Oxygen; Rats; Rats, Inbred Strains; Sulfinpyrazone; Verapamil | 1987 |
[Prostaglandin studies in normal subjects and in post-myocardial infarct patients].
Topics: Adult; Aspirin; Child; Dinoprost; Female; Humans; Indomethacin; Male; Myocardial Infarction; Physical Exertion; Prostaglandins F; Renin-Angiotensin System; Sulfinpyrazone | 1985 |
Differential inhibition of platelet thromboxane and lung prostacyclin production by sulphinpyrazone, acetylsalicylic acid and indomethacin by human tissues in vitro.
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Epoprostenol; Humans; In Vitro Techniques; Indomethacin; Lung; Sulfinpyrazone; Thromboxane A2; Thromboxane B2 | 1985 |
Interaction of non-steroidal anti-inflammatory drugs on platelet cyclo-oxygenase and lipoxygenase activity.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Humans; Indomethacin; Kinetics; Lipoxygenase; Models, Biological; Prostaglandin-Endoperoxide Synthases; Salicylates; Salicylic Acid; Sulfinpyrazone | 1985 |
Hyperuricemia and gout.
Topics: Allopurinol; Anti-Inflammatory Agents; Arthritis; Colchicine; Female; Gout; Humans; Indomethacin; Kidney Calculi; Male; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid | 1985 |
Zyloprim and other drugs in the management of gout.
Topics: Adrenocorticotropic Hormone; Colchicine; Enzyme Therapy; Enzymes; Gout; Humans; Indomethacin; Probenecid; Sulfinpyrazone; Urinary Calculi; Xanthine Oxidase | 1966 |
[The treatment of gout and the internal medical treatment of uric acid nephrolithiasis].
Topics: Adrenocorticotropic Hormone; Allopurinol; Colchicine; Gout; Humans; Indomethacin; Kidney Calculi; Prednisolone; Probenecid; Sulfinpyrazone; Uricosuric Agents | 1968 |
[How to treat gout].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anticoagulants; Benzofurans; Colchicine; Gout; Griseofulvin; Humans; Indomethacin; Oxyphenbutazone; Phenylbutazone; Probenecid; Salicylates; Sulfinpyrazone | 1966 |
Interaction of non-steroidal antiinflammatory agents with corticosterone binding to plasma proteins in the rat.
Topics: Adrenocorticotropic Hormone; Animals; Anti-Inflammatory Agents; Blood Proteins; Corticosterone; Flufenamic Acid; Indomethacin; Male; Mefenamic Acid; Oxyphenbutazone; Phenylbutazone; Plasma; Protein Binding; Rats; Sodium Salicylate; Stimulation, Chemical; Sulfinpyrazone; Tritium | 1969 |
Cartilage cyclic nucleotide phosphodiesterase: inhibition by anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents; Bucladesine; Cartilage; Cartilage, Articular; Chickens; Cyclic AMP; Cyclic GMP; Dopamine; Epinephrine; Epiphyses; Gold; Indomethacin; Kinetics; Mefenamic Acid; Oxyphenbutazone; Papaverine; Phenylbutazone; Phosphodiesterase Inhibitors; Quinolines; Structure-Activity Relationship; Sulfinpyrazone; Theophylline; Tritium | 1974 |
Bradykinin induced bronchoconstriction in guinea pigs and its modification by various agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antipyrine; Aspirin; Bradykinin; Bronchi; Chlorpromazine; Drug Antagonism; Drug Synergism; Ethanolamines; Female; Guinea Pigs; Histamine; Indomethacin; Male; Methysergide; Oxyphenbutazone; Phenacetin; Phenoxybenzamine; Phenylbutazone; Sulfinpyrazone; Tripelennamine | 1967 |
[Incidence of thrombosis and the status of coagulation in ischaemic heart disease].
Topics: Acute Disease; Aspirin; Blood Coagulation; Chronic Disease; Coronary Disease; Depression, Chemical; Humans; Indomethacin; Myocardial Infarction; Phenylbutazone; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone | 1974 |
The treatment of gout.
Topics: Acute Disease; Allopurinol; Aspirin; Colchicine; Drug Therapy, Combination; Gout; Indomethacin; Phenylbutazone; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1973 |
The binding of urate to plasma proteins.
Topics: Allopurinol; Aspirin; Binding Sites; Blood Proteins; Colchicine; Dialysis; Evaluation Studies as Topic; Gout; Humans; Hydrogen-Ion Concentration; Indomethacin; Kidney Diseases; Kinetics; Methods; Osmolar Concentration; Phenylbutazone; Probenecid; Protein Binding; Serum Albumin; Solubility; Sulfinpyrazone; Temperature; Time Factors; Uric Acid | 1974 |
[Gout from the view of a special hospital for rheumatic patients].
Topics: Acute Disease; Adolescent; Adult; Aged; Austria; Child; Cholesterol; Colchicine; Colic; Diabetes Complications; Diagnosis, Differential; Diagnostic Errors; Gout; Heart Diseases; Hospitals, Special; Humans; Indomethacin; Kidney Diseases; Middle Aged; Obesity; Phenylbutazone; Probenecid; Prognosis; Radiography; Rheumatic Diseases; Sulfinpyrazone; Time Factors; Uric Acid; Uricosuric Agents | 1971 |
[Gout in dermatology].
Topics: Adolescent; Aged; Colchicine; Diagnosis, Differential; Gout; Humans; Indomethacin; Joint Diseases; Male; Middle Aged; Osteoporosis; Phenylbutazone; Probenecid; Radiography; Skin Diseases; Skin Ulcer; Sulfinpyrazone; Toes | 1969 |
Effect of drugs on the binding of urate to human albumin.
Topics: Allopurinol; Aspirin; Colchicine; Humans; Indomethacin; Phenylbutazone; Probenecid; Protein Binding; Serum Albumin; Sulfinpyrazone; Uric Acid | 1970 |
Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets.
Topics: Adenine Nucleotides; Anti-Inflammatory Agents; Aspirin; Blood Platelets; Carbon Isotopes; Centrifugation; Connective Tissue; Dipyridamole; Drug Synergism; Epinephrine; Flufenamic Acid; Humans; Indomethacin; Mefenamic Acid; Phenylbutazone; Serotonin; Sodium Salicylate; Sulfinpyrazone | 1970 |
Effect of some uricosuric and anti-inflammatory drugs on the binding of uric acid to human serum albumin in vitro.
Topics: Allopurinol; Anti-Inflammatory Agents; Aspirin; Binding Sites; Caprylates; Colchicine; Dialysis; Fluorescence; Humans; In Vitro Techniques; Indomethacin; Mefenamic Acid; Phenylbutazone; Probenecid; Protein Binding; Serum Albumin; Sodium Salicylate; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1970 |
Etiology and treatment of gout--modern concepts.
Topics: Allopurinol; Colchicine; Crystallization; Diagnosis, Differential; Diet Therapy; Gout; Humans; Indomethacin; Joint Diseases; Kidney Diseases; Kidneys, Artificial; Phenylbutazone; Probenecid; Proteinuria; Purines; Radiography; Salicylates; Steroids; Sulfinpyrazone; Uric Acid | 1968 |
The pharmaceutical treatment of gout.
Topics: Enzyme Therapy; Gout; Humans; Indomethacin; Phenylbutazone; Sulfinpyrazone; Uric Acid; Xanthine Oxidase | 1966 |
Induction of periarthritis by oral administration of 6-sulfanilamidoindazole and its treatment in rats.
Topics: Animals; Aspirin; Chloroquine; Cloxacillin; Hydralazine; Hydrocortisone; Indomethacin; Male; Mercaptopurine; Methotrexate; Morphine; ortho-Aminobenzoates; Oxyphenbutazone; Paramethasone; Periarthritis; Phenylbutazone; Rats; Sulfinpyrazone; Sulfonamides | 1967 |
Differential inhibition of neutrophil superoxide generation by nonsteroidal antiinflammatory drugs.
Topics: Anti-Inflammatory Agents; Humans; In Vitro Techniques; Indomethacin; Kinetics; Neutrophils; Phenylbutazone; Sulfinpyrazone; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1984 |
[Current status of medical treatment].
Topics: Aminophylline; Animals; Anticoagulants; Aspirin; Barbiturates; Brain Ischemia; Cerebrovascular Disorders; Dextrans; Epoprostenol; Glucose; Glycerol; Heparin; Humans; Indomethacin; Pentoxifylline; Sulfinpyrazone | 1980 |
Studies on the effect of indomethacin and sulfinpyrazone on the rates of synthesis of albumin and acute-phase alpha 1-acid glycoprotein by rat liver slices.
Topics: Albumins; Animals; Indomethacin; Liver; Male; Orosomucoid; Orotic Acid; Phenylbutazone; Rats; RNA; Salicylates; Sulfinpyrazone | 1982 |
[Prevention of thrombosis by thrombocyte inhibitors. 1. Cell regulation mechanisms and pharmacological modification].
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Cyclic AMP; Dextrans; Dipyridamole; Humans; Hydroxychloroquine; Indomethacin; Platelet Aggregation; Prostaglandins; Sulfinpyrazone; Thrombosis; Thromboxane A2 | 1980 |
Thromboxane formation during blood clotting is decreased by verapamil.
Topics: Blood Coagulation; Blood Platelets; Humans; Indomethacin; Methacrylates; Sulfinpyrazone; Thromboxane B2; Thromboxanes; Verapamil | 1984 |
Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Aspirin; Blood Platelets; Catechols; Chromones; Dose-Response Relationship, Drug; Guinea Pigs; Indomethacin; Lung; Masoprocol; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Rats; Sulfinpyrazone; Thromboxane B2 | 1983 |
Protection from arrhythmias of cultured heart cells by nonsteroidal antiinflammatory drugs.
Topics: Animals; Animals, Newborn; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Aspirin; Cells, Cultured; Indomethacin; Rats; Salicylates; Salicylic Acid; Sulfinpyrazone; Time Factors | 1983 |
[Study of platelet aggregation by the filtration pressure method (author's transl)].
Topics: Adenosine Diphosphate; Alprostadil; Animals; Bradykinin; Dogs; Epoprostenol; Female; Filtration; Indomethacin; Male; Platelet Aggregation; Platelet Count; Pressure; Prostaglandins E; Sulfinpyrazone; Vasodilator Agents | 1981 |
[Sulfinpyrazone-associated renal failure (author's transl)].
Topics: Acute Kidney Injury; Adult; Aged; Blood Urea Nitrogen; Creatinine; Female; Humans; Indomethacin; Male; Mexiletine; Middle Aged; Myocardial Infarction; Sulfinpyrazone | 1982 |
Drug-induced renal failure.
Topics: Humans; Indomethacin; Kidney Failure, Chronic; Myocardial Infarction; Sulfinpyrazone | 1982 |
Inhibitors of immune complex induced human platelet aggregation and release in plasma.
Topics: Antibodies; Antigen-Antibody Complex; Aspirin; Blood Platelets; Depression, Chemical; Dipyridamole; DNA; Humans; Imidazoles; Indomethacin; Lupus Erythematosus, Systemic; Male; Platelet Aggregation; Quinazolines; Receptors, Fc; Sulfinpyrazone | 1982 |
Effect of non-steroid anti-inflammatory drugs in experimental myocardial infarction in rats.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Coronary Vessels; Indomethacin; Male; Myocardial Infarction; Rats; Salicylates; Sulfinpyrazone | 1981 |
Practical therapeutics treatment of gout.
Topics: Colchicine; Female; Gout; Humans; Indomethacin; Male; Phenylbutazone; Probenecid; Sulfinpyrazone | 1981 |
Mechanisms of Forssman-induced bronchospasm and their inhibition.
Topics: Animals; Aspirin; Blood Platelets; Bronchial Spasm; Complement System Proteins; Forssman Antigen; Guinea Pigs; Immune Sera; Indomethacin; Neuraminidase; Pressure; Salicylates; Sulfinpyrazone | 1981 |
A platelet-derived factor chemotactic for rabbit arterial smooth muscle cells in culture.
Topics: Animals; Aorta, Thoracic; Blood Platelets; Cells, Cultured; Chemotactic Factors; Chemotaxis; Collagen; Indomethacin; Muscle, Smooth, Vascular; Rabbits; Sulfinpyrazone; Thrombin | 1981 |
Sulphinpyrazone and indomethacin for inhibition of platelet prostaglandin synthesis.
Topics: Blood Platelets; Humans; Indomethacin; Male; Malondialdehyde; Prostaglandins; Sulfinpyrazone | 1981 |
Relationship of plasma anti-heparin activity and platelet survival time in coronary disease.
Topics: Aspirin; Blood Coagulation Factors; Blood Platelets; Cell Survival; Coronary Disease; Dipyridamole; Double-Blind Method; Humans; Indomethacin; Male; Platelet Factor 4; Sulfinpyrazone; Time Factors | 1980 |
Prostaglandin production associated with the pulmonary vascular response to complement activation.
Topics: Animals; Blood Pressure; Cardiac Output; Complement Activation; Female; Indomethacin; Leukocyte Count; Male; Oxygen; Prostaglandins F; Pulmonary Artery; Pulmonary Circulation; Sheep; Sulfinpyrazone; Thromboxane B2; Vascular Resistance | 1980 |
Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.
Topics: Agranulocytosis; Arachidonic Acids; Aspirin; Cell Adhesion; Chemotactic Factors; Chemotaxis, Leukocyte; Dose-Response Relationship, Drug; Humans; Indomethacin; Methionine; N-Formylmethionine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Phenylbutazone; Sulfinpyrazone | 1980 |
Comparison of the uricosuric effect of sulfinpyrazone (anturan) and zoxazolamine (flexin).
Topics: Humans; Indomethacin; Phenylbutazone; Sulfinpyrazone; Uric Acid; Zoxazolamine | 1960 |
GOUT.
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Colchicine; Diagnosis, Differential; Diet; Diet Therapy; Drug Therapy; Epidemiology; Genetics, Medical; Gout; Humans; Indomethacin; Kidney Diseases; Kidneys, Artificial; Phenylbutazone; Probenecid; Salicylates; Sulfinpyrazone; Uric Acid; Urine | 1964 |
Interactions of urate transporter URAT1 in human kidney with uricosuric drugs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzbromarone; Benzothiazoles; Biological Transport; Captopril; Cells, Cultured; Dogs; Enalapril; Indomethacin; Inhibitory Concentration 50; Organic Anion Transporters; Organic Cation Transport Proteins; Phenylbutazone; Probenecid; Pyridines; Salicylates; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 2011 |
Computational Insights on the Potential of Some NSAIDs for Treating COVID-19: Priority Set and Lead Optimization.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Auranofin; Binding Sites; Computational Biology; Coronavirus 3C Proteases; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Databases, Chemical; Drug Repositioning; Humans; Indomethacin; Ligands; Models, Molecular; Molecular Docking Simulation; Molecular Dynamics Simulation; Protease Inhibitors; Protein Binding; SARS-CoV-2; Structure-Activity Relationship; Sulfinpyrazone; United States; United States Food and Drug Administration | 2021 |